TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

J F Knight, C J Shepherd, S Rizzo, D Brewer, S Jhavar, A R Dodson, C S Cooper, R Eeles, A Falconer, G Kovacs, M D Garrett, A R Norman, J Shipley, D L Hudson
  • British Journal of Cancer, November 2008, Nature Publishing Group
  • DOI: 10.1038/sj.bjc.6604774

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/sj.bjc.6604774

The following have contributed to this page: Dr Daniel Brewer

In partnership with: